ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,339,000 | -92.0% | 28,900 | -95.8% | 0.05% | -91.9% |
| Q1 2019 | $16,728,000 | +166.3% | 686,100 | +55.6% | 0.58% | +140.1% |
| Q4 2018 | $6,282,000 | -22.3% | 440,800 | -17.1% | 0.24% | -32.6% |
| Q3 2018 | $8,082,000 | +60.8% | 531,700 | +77.5% | 0.36% | +31.5% |
| Q2 2018 | $5,026,000 | +145.8% | 299,500 | +139.0% | 0.27% | +78.4% |
| Q1 2018 | $2,045,000 | +1485.3% | 125,312 | +1146.3% | 0.15% | +1290.9% |
| Q4 2017 | $129,000 | -84.2% | 10,055 | -91.7% | 0.01% | -92.1% |
| Q3 2016 | $819,000 | – | 121,309 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |